Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
AffaMed Therapeutics Announces Partner Vistagen Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder 2023-08-10 15:49
1